CUSIP 29664W105COMESPRQ4 2025
Aggregate 13F value by quarter
Multi-quarter trend — upgrade to see history
UpgradeQ4 2025
198 funds hold this security · Q4 2025
| # | Fund | Shares | Value | Δ Shares | Activity |
|---|---|---|---|---|---|
| 1 | Blackrock, Inc. | 17.68M | $65.42M | +2.85M | Added |
| 2 | Vanguard Group Inc | 14.95M | $55.30M | +2.85M | Added |
| 3 | Two Seas Capital LP | 11.90M | $44.04M | +2.15M | Added |
| 4 | Wasatch Advisors LP | 9.45M | $34.95M |
| Added |
| 5 | D. E. Shaw & Co., Inc. | 6.90M | $25.54M | +6.69M | Added |
| 6 | Orbimed Advisors LLC | 5.97M | $22.07M | +5.97M | New |
| 7 | State Street Corp | 5.93M | $21.94M | +1.45M | Added |
| 8 | Geode Capital Management, LLC | 5.74M | $21.23M | +986.3K | Added |
| 9 | Marshall Wace, LLP | 5.47M | $20.24M | +2.95M | Added |
| 10 | Two Sigma Investments, LP | 4.74M | $17.55M | +2.50M | Added |
See every fund holding Esperion Therapeutics Inc Ne, with full quarter-over-quarter share changes.
Unlock all holders